| 1. |
From the Editor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1133KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
Heparin - one HIT too many? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 3-4
Sean Henahan,
Preview
|
PDF (2042KB)
|
|
摘要:
The increasing incidence of heparin-induced thrombocytopenia (HIT) is raising concern among haematologists worldwide. In response to the latest data, attention is now focusing on alternative antithrombotic agents and on increased awareness of early warning signals of HIT development. The latest findings were presented at the 13th Annual Conference on Clinical Hematology and Oncology [La Jolla, California, US; February 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
New influenza vaccine formula announced by WHO |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 4-4
&NA;,
Preview
|
PDF (1048KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
How much do we know about epoetin-&agr; in neonatal anaemia? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 5-5
&NA;,
Preview
|
PDF (1007KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
Costs associated with drug-related hospitalisation |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1148KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 7-7
&NA;,
Preview
|
PDF (1056KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1106KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
Latest attempts to deliver oligonucleotides to the brain |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 9-9
Robert Short,
Preview
|
PDF (1065KB)
|
|
摘要:
A major obstacle to the successful therapeutic use of oligonucleotides is their poor delivery to target cells. This is a particular problem for therapies developed to treat brain diseases, such as glioblastomas. However, a number of research teams are working on strategies to improve the passage of oligonucleotides across the blood:brain barrier. The latest progress in this respect was reported at the IIR Ltd conference, entitled ‘Antisense Therapy: Efficacy and Delivery of Antisense & Ribozyme Oligonucleotides’ [London, UK; February 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 10-11
&NA;,
Preview
|
PDF (2024KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
News in brief . . |
| |
Inpharma Weekly,
Volume &NA;,
Issue 978,
1995,
Page 11-11
&NA;,
Preview
|
PDF (960KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
